{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:49:20Z","timestamp":1784126960303,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1136\/ijgc-2020-001271","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T02:34:33Z","timestamp":1590719673000},"page":"975-980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0231-8330","authenticated-orcid":false,"given":"Woo Yeon","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hoon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9254-6024","authenticated-orcid":false,"given":"Kidong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hong","family":"No","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001271_bb0010","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e40","article-title":"Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri","volume":"30","author":"Berek","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143(Suppl 2)","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2020-001271_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"10.1136\/ijgc-2020-001271_bb0025","author":"National Comprehensive Cancer Network","year":"2019","journal-title":"Clinical practice guideline in oncology, cervical cancer (version 5)"},{"key":"10.1136\/ijgc-2020-001271_bb0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001271_bb0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9378(76)90668-2","article-title":"Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion)","volume":"126","author":"Morley","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001271_bb0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2007.08.056","article-title":"Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis","volume":"107","author":"Jewell","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a Gynecologic Oncology Group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2020-001271_bb0055","article-title":"Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer","volume":"10","author":"Nama","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2020-001271_bb0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rpor.2012.07.005","article-title":"Incidence of radiation toxicity in cervical cancer and endometrial cancer patients treated with radiotherapy alone versus adjuvant radiotherapy","volume":"17","author":"Roszak","year":"2012","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1136\/ijgc-2020-001271_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/1754-9485.12411","article-title":"Stage IB cervix cancer with nodal involvement treated with primary surgery or primary radiotherapy: patterns of failure and outcomes in a contemporary population","volume":"60","author":"Lapuz","year":"2016","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jfma.2018.01.015","article-title":"Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +\/\u2212 neoadjuvant chemotherapy","volume":"118","author":"Hsieh","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1136\/ijgc-2020-001271_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jjco\/hyw145","article-title":"Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors","volume":"47","author":"Seki","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.2000.6010","article-title":"Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study","volume":"80","author":"Landoni","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-017-0856-2","article-title":"Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma","volume":"12","author":"Moreno-Acosta","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ol_00000001","article-title":"Treatment options in recurrent cervical cancer (review)","volume":"1","author":"Gadducci","year":"2010","journal-title":"Oncol Lett"},{"key":"10.1136\/ijgc-2020-001271_bb0095","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ygyno.2004.11.007","article-title":"Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group\/Southwest Oncology Group\/Radiation Therapy Oncology Group trial","volume":"96","author":"Monk","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5732\/cjc.009.10528","article-title":"Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma","volume":"29","author":"Yan","year":"2010","journal-title":"Chin J Cancer"},{"key":"10.1136\/ijgc-2020-001271_bb0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ygyno.2005.01.004","article-title":"Clinical significance of lymphovascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study","volume":"97","author":"Marchiol\u00e9","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0110","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1200\/JCO.2006.07.4799","article-title":"Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651\/GOG 183 intergroup study","volume":"24","author":"Mitchell","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1102\/1470-7330.2007.0011","article-title":"Magnetic resonance imaging of the cervix","volume":"7","author":"Zand","year":"2007","journal-title":"Cancer Imaging"},{"key":"10.1136\/ijgc-2020-001271_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-019-0696-8","article-title":"Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers","volume":"10","author":"Otero-Garc\u00eda","year":"2019","journal-title":"Insights Imaging"},{"key":"10.1136\/ijgc-2020-001271_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0090-8258(03)00409-8","article-title":"Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review","volume":"91","author":"Bipat","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001271_bb0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ygyno.2012.09.025","article-title":"Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial","volume":"128","author":"Epstein","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:38:26Z","timestamp":1753223906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1048891X24001981"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001271","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/.","name":"copyright","label":"Copyright"}]}}